Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein

Cell Reports

Volumn 12, Issue 3, 2015, Pages 462-473

  Klinman, Eva ^a   Holzbaur, Erika L F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; DYNEIN ADENOSINE TRIPHOSPHATASE; LIS1 PROTEIN; NDEL1 PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CARRIER PROTEIN; CDK5 PROTEIN, HUMAN; CDK5 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; NDEL1 PROTEIN, HUMAN; NDEL1 PROTEIN, MOUSE; PAFAH1B1 PROTEIN, HUMAN; PAFAH1B1 PROTEIN, MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; LYSOSOME; MITOCHONDRION; MOUSE; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONAL TRANSPORT; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; DYNEINS; ENDOSOMES; HELA CELLS; HUMANS; LYSOSOMES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS;

EID: 84937513345     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.032     Document Type: Article

References (44)

1. Ayloo S., Lazarus J.E., Dodda A., Tokito M., Ostap E.M., Holzbaur E.L.F. Dynactin functions as both a dynamic tether and brake during dynein-driven motility. Nat. Commun. 2014, 5:4807.
2. Bilsland L.G., Sahai E., Kelly G., Golding M., Greensmith L., Schiavo G. Deficits in axonal transport precede ALS symptoms invivo. Proc. Natl. Acad. Sci. USA 2010, 107:20523-20528.
3. Bradshaw N.J., Hennah W., Soares D.C. NDE1 and NDEL1: twinneurodevelopmental proteins with similar 'nature' but different 'nurture'. Biomol Concepts 2013, 4:447-464.
4. Cozzolino M., Pesaresi M.G., Gerbino V., Grosskreutz J., Carrì M.T. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid. Redox Signal. 2012, 17:1277-1330.
5. Dhariwala F.A., Rajadhyaksha M.S. An unusual member of the Cdk family: Cdk5. Cell. Mol. Neurobiol. 2008, 28:351-369.
6. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
7. Fu M.M., Holzbaur E.L.F. Integrated regulation of motor-driven organelle transport by scaffolding proteins. Trends Cell Biol. 2014, 24:564-574.
8. Goodwin P.R., Sasaki J.M., Juo P. Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J.Neurosci. 2012, 32:8158-8172.
9. Hallows J.L., Chen K., DePinho R.A., Vincent I. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J.Neurosci. 2003, 23:10633-10644.
10. Hancock W.O. Bidirectional cargo transport: moving beyond tug of war. Nat. Rev. Mol. Cell Biol. 2014, 15:615-628.
11. Hebbar S., Mesngon M.T., Guillotte A.M., Desai B., Ayala R., Smith D.S. Lis1 and Ndel1 influence the timing of nuclear envelope breakdown in neural stem cells. J.Cell Biol. 2008, 182:1063-1071.
12. Henriques A., Pitzer C., Schneider A. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?. Front Neurosci 2010, 4:32.
13. Huang J., Roberts A.J., Leschziner A.E., Reck-Peterson S.L. Lis1 acts as a "clutch" between the ATPase and microtubule-binding domains of the dynein motor. Cell 2012, 150:975-986.
14. Kiyomitsu T., Cheeseman I.M. Chromosome- and spindle-pole-derived signals generate an intrinsic code for spindle position and orientation. Nat. Cell Biol. 2012, 14:311-317.
15. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
16. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T., Hisanaga S. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J.Biol. Chem. 2000, 275:17166-17172.
17. Maday S., Wallace K.E., Holzbaur E.L.F. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J.Cell Biol. 2012, 196:407-417.
18. Maday S., Twelvetrees A.E., Moughamian A.J., Holzbaur E.L.F. Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron 2014, 84:292-309.
19. Magrané J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014, 23:1413-1424.
20. McKenney R.J., Vershinin M., Kunwar A., Vallee R.B., Gross S.P. LIS1 and NudE induce a persistent dynein force-producing state. Cell 2010, 141:304-314.
21. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 1997, 243:527-536.
22. Menn B., Bach S., Blevins T.L., Campbell M., Meijer L., Timsit S. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits invivo CDK5 activity increase in animal stroke models. PLoS ONE 2010, 5:e12117.
23. Mesngon M.T., Tarricone C., Hebbar S., Guillotte A.M., Schmitt E.W., Lanier L., Musacchio A., King S.J., Smith D.S. Regulation of cytoplasmic dynein ATPase by Lis1. J.Neurosci. 2006, 26:2132-2139.
24. Meuer K., Suppanz I.E., Lingor P., Planchamp V., Göricke B., Fichtner L., Braus G.H., Dietz G.P.H., Jakobs S., Bähr M., Weishaupt J.H. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ. 2007, 14:651-661.
25. Modi P.K., Komaravelli N., Singh N., Sharma P. Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons. Mol. Biol. Cell 2012, 23:3722-3730.
26. Morel M., Authelet M., Dedecker R., Brion J.P. Glycogen synthase kinase-3beta and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons. Neuroscience 2010, 167:1044-1056.
27. Morfini G., Szebenyi G., Brown H., Pant H.C., Pigino G., DeBoer S., Beffert U., Brady S.T. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 2004, 23:2235-2245.
28. Moughamian A.J., Holzbaur E.L.F. Dynactin is required for transport initiation from the distal axon. Neuron 2012, 74:331-343.
29. Moughamian A.J., Osborn G.E., Lazarus J.E., Maday S., Holzbaur E.L.F. Ordered recruitment of dynactin to the microtubule plus-end is required for efficient initiation of retrograde axonal transport. J.Neurosci. 2013, 33:13190-13203.
30. Nguyen M.D., Larivière R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30:135-147.
31. Niethammer M., Smith D.S., Ayala R., Peng J., Ko J., Lee M.S., Morabito M., Tsai L.H. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 2000, 28:697-711.
32. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. Thecdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 1996, 10:816-825.
33. Ou C.-Y., Poon V.Y., Maeder C.I., Watanabe S., Lehrman E.K., Fu A.K.Y., Park M., Fu W.-Y., Jorgensen E.M., Ip N.Y., Shen K. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell 2010, 141:846-858.
34. Pandey J.P., Smith D.S. A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J.Neurosci. 2011, 31:17207-17219.
35. Patrick G.N., Zhou P., Kwon Y.T., Howley P.M., Tsai L.-H. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J.Biol. Chem. 1998, 273:24057-24064.
36. Perlson E., Jeong G.-B., Ross J.L., Dixit R., Wallace K.E., Kalb R.G., Holzbaur E.L.F. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J.Neurosci. 2009, 29:9903-9917.
37. Schroeder H.W., Mitchell C., Shuman H., Holzbaur E.L.F., Goldman Y.E. Motor number controls cargo switching at actin-microtubule intersections invitro. Curr. Biol. 2010, 20:687-696.
38. Shukla V., Skuntz S., Pant H.C. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch. Med. Res. 2012, 43:655-662.
39. Su S.C., Tsai L.-H. Cyclin-dependent kinases in brain development and disease. Annu. Rev. Cell Dev. Biol. 2011, 27:465-491.
40. Tsai L.H., Takahashi T., Caviness V.S., Harlow E. Activity andexpression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 1993, 119:1029-1040.
41. Wynshaw-Boris A. Lissencephaly and LIS1: insights into the molecularmechanisms of neuronal migration and development. Clin. Genet. 2007, 72:296-304.
42. Zhang L., Liu W., Szumlinski K.K., Lew J. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 2012, 109:20041-20046.
43. Zheng Y.-L., Li B.-S., Kanungo J., Kesavapany S., Amin N., Grant P., Pant H.C. Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol. Biol. Cell 2007, 18:404-413.
44. Zyłkiewicz E., Kijańska M., Choi W.-C., Derewenda U., Derewenda Z.S., Stukenberg P.T. The N-terminal coiled-coil of Ndel1 is a regulated scaffold that recruits LIS1 to dynein. J.Cell Biol. 2011, 192:433-445.